Medical Devices & Surgical Technology Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices & Surgical Technology Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cell Therapy
Intercytex announces introduction of Vavelta at FACE - the UK's largest medical aesthetic conference
July 22nd, 2007
Intercytex Group plc, the cell therapy company focused on aesthetic medicine and tissue repair, announces that it has introduced VAVELTA, its facial rejuvenation product, for the first time at the Facial Aesthetic Conference and Exhibition (FACE) held from 29th June to 1st July in London. FACE is the largest medical aesthetic conference in the UK for practitioners and clinics that deliver predominantly non-surgical medical aesthetic treatments. VAVELTA is on track for launch in the second half of 2007 and will be launched initially with a selected group of physicians who have significant experience in the use of cell therapy for facial rejuvenation. It is expected that...
Source: Medical Devices & Surgical Technology Week (2007-07-22)
|
